• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

乳腺癌预防与治疗的个性化方法

Personalized Approaches for the Prevention and Treatment of Breast Cancer.

作者信息

Nabi Hermann

机构信息

Oncology Division, CHU de Québec-Université Laval Research Center, Quebec City, QC G1S 4L8, Canada.

Université Laval Cancer Research Center (CRC), Université Laval, Quebec City, QC G1S 4L8, Canada.

出版信息

J Pers Med. 2022 Jul 23;12(8):1201. doi: 10.3390/jpm12081201.

DOI:10.3390/jpm12081201
PMID:35893295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9331702/
Abstract

Breast cancer (BC) remains a major public health issue worldwide [...].

摘要

乳腺癌（BC）仍是全球范围内一个重大的公共卫生问题[...]。

相似文献

1
Personalized Approaches for the Prevention and Treatment of Breast Cancer.乳腺癌预防与治疗的个性化方法
J Pers Med. 2022 Jul 23;12(8):1201. doi: 10.3390/jpm12081201.
2
The next generation personalized models to screen hidden layers of breast cancer tumorigenicity.下一代个性化模型筛选乳腺癌肿瘤发生的隐藏层。
Breast Cancer Res Treat. 2019 Jun;175(2):277-286. doi: 10.1007/s10549-019-05159-2. Epub 2019 Feb 27.
3
'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'.通过综合多组学技术实现乳腺癌耐药可能性及个性化治疗
Front Mol Biosci. 2022 Apr 14;9:783494. doi: 10.3389/fmolb.2022.783494. eCollection 2022.
4
Endocrine prevention of breast cancer.乳腺癌的内分泌预防。
Mol Cell Endocrinol. 2021 Jun 15;530:111284. doi: 10.1016/j.mce.2021.111284. Epub 2021 Apr 18.
5
Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.植物天然调节剂在乳腺癌预防中的应用：预测、预防和个性化医疗方法强化下的现状与未来展望
EPMA J. 2018 Nov 12;9(4):403-419. doi: 10.1007/s13167-018-0154-6. eCollection 2018 Dec.
6
Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines - Pilot Study.基于个性化乳腺癌风险分层的筛查策略调整及其在国家指南中的实施——试点研究
Zdr Varst. 2020 Oct 18;59(4):211-218. doi: 10.2478/sjph-2020-0027. eCollection 2020 Dec.
7
Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.CDH1在乳腺癌中的临床病理意义及潜在药物靶点：一项荟萃分析与文献综述
Drug Des Devel Ther. 2015 Sep 18;9:5277-85. doi: 10.2147/DDDT.S86929. eCollection 2015.
8
Long Non-Coding RNA in Breast Cancer Therapy.长链非编码RNA在乳腺癌治疗中的作用
Cancers (Basel). 2020 May 9;12(5):1197. doi: 10.3390/cancers12051197.
9
Global Perceptions of Women on Breast Cancer and Barriers to Screening.全球女性对乳腺癌的认知及筛查障碍
Curr Oncol Rep. 2021 May 3;23(7):74. doi: 10.1007/s11912-021-01069-z.
10
Californians Linking Action with Science for Prevention of Breast Cancer (CLASP-BC)-Phase 2.加利福尼亚人行动与科学预防乳腺癌联盟（CLASP-BC）-第 2 阶段。
Int J Environ Res Public Health. 2020 Nov 28;17(23):8863. doi: 10.3390/ijerph17238863.

引用本文的文献

1
Computational Analyses Reveal Deregulated Clock Genes Associated with Breast Cancer Development in Night Shift Workers.计算分析揭示了与夜班工人乳腺癌发展相关的失调时钟基因。
Int J Mol Sci. 2024 Aug 8;25(16):8659. doi: 10.3390/ijms25168659.

本文引用的文献

1
Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada.风险分层与癌症随访：加拿大迈向更具个性化的治疗后护理。
Curr Oncol. 2022 May 3;29(5):3215-3223. doi: 10.3390/curroncol29050261.
2
Adjuvant Whole Breast Radiotherapy Improve Survival in Women with Heart Failure with Reduced Ejection Fraction Receiving Breast-Conserving Surgery.辅助性全乳放疗可提高接受保乳手术的射血分数降低的心力衰竭女性患者的生存率。
J Pers Med. 2021 Dec 13;11(12):1358. doi: 10.3390/jpm11121358.
3
A Focus Group Study of Perceptions of Genetic Risk Disclosure in Members of the Public in Sweden: "I'll Phone the Five Closest Ones, but What Happens to the Other Ten?".瑞典公众对基因风险披露认知的焦点小组研究：“我会给最亲近的五个人打电话，但另外十个人怎么办？”
J Pers Med. 2021 Nov 12;11(11):1191. doi: 10.3390/jpm11111191.
4
The current status of risk-stratified breast screening.风险分层乳腺癌筛查的现状。
Br J Cancer. 2022 Mar;126(4):533-550. doi: 10.1038/s41416-021-01550-3. Epub 2021 Oct 26.
5
Identifying Clinicopathological Factors Associated with Oncotype DX 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada.确定与Oncotype DX 21基因复发评分相关的临床病理因素：加拿大魁北克市乳腺癌患者的一项真实世界回顾性队列研究。
J Pers Med. 2021 Aug 28;11(9):858. doi: 10.3390/jpm11090858.
6
Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients.乳腺癌患者中大麻素受体CBR1和CBR2的乳腺肿瘤表达与预后因素及生存的关联
J Pers Med. 2021 Aug 28;11(9):852. doi: 10.3390/jpm11090852.
7
The WISDOM study: a new approach to screening can and should be tested.智慧研究：一种新的筛查方法能够且应该得到检验。
Breast Cancer Res Treat. 2021 Oct;189(3):593-598. doi: 10.1007/s10549-021-06346-w. Epub 2021 Sep 16.
8
Breast Cancer Treatments: Updates and New Challenges.乳腺癌治疗：进展与新挑战
J Pers Med. 2021 Aug 19;11(8):808. doi: 10.3390/jpm11080808.
9
Of Screening, Stratification, and Scores.关于筛查、分层和评分
J Pers Med. 2021 Jul 28;11(8):736. doi: 10.3390/jpm11080736.
10
Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data.加拿大乳腺癌筛查的风险分层方法：女性对立法背景的了解以及对基因和其他预测性健康数据导致歧视的担忧。
J Pers Med. 2021 Jul 27;11(8):726. doi: 10.3390/jpm11080726.